Rapid Micro Biosystems RPID Weighted Average Exercise Price of Outstanding Options
Weighted Average Exercise Price of Outstanding Options at other companies
Other financials
Where this comes from
Reported directly by Rapid Micro Biosystems in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.
The official record: Rapid Micro Biosystems’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rapid Micro Biosystems's weighted average exercise price of outstanding options.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rapid Micro Biosystems's weighted average exercise price of outstanding options?
- Rapid Micro Biosystems (RPID) reported weighted average exercise price of outstanding options of $2.74 in Q1 2026.
- How has Rapid Micro Biosystems's weighted average exercise price of outstanding options changed year-over-year?
- Rapid Micro Biosystems's weighted average exercise price of outstanding options increased by 7.9% year-over-year, from $2.54 to $2.74.
- What is the long-term trend for Rapid Micro Biosystems's weighted average exercise price of outstanding options?
- Over 4 years (2021 to 2025), Rapid Micro Biosystems's weighted average exercise price of outstanding options has grown at a -16.8% compound annual growth rate (CAGR), from $5.06 to $2.43.
- What does weighted average exercise price of outstanding options mean?
- This metric calculates the average price at which holders of outstanding stock options can purchase company shares. It provides context on the 'in-the-money' status of employee compensation packages. When compared to the current market price, it helps assess the alignment between employee incentives and shareholder value.